Abstract
A series of fluorophenylpyrazole-picolinamide derivatives were synthesized in high yields using a cross-coupling reaction catalyzed byin situformed palladium-N-heterocyclic carbenes (Pd-NHCs). The synthesized novel derivatives were evaluated forin vitroanticancer activity against a panel of four human tumor cell lines, HeLa (cervical), A-549 (lung), MCF-7 (breast), and IMR-32 (neuroblastoma). Four compounds,11c,11e,11j, and11k, showed growth inhibition (low mu M) comparable with the standard drug cisplatin, providing a preliminary structure-activity relationship for the series. The present procedure is operationally simple and works with a wide range of substrates and may thus be useful in further compound optimization.
Original language | English |
---|---|
Journal | Synthetic Communications |
Volume | 50 |
Issue number | 19 |
Pages (from-to) | 2997-3006 |
Number of pages | 10 |
ISSN | 0039-7911 |
DOIs | |
Publication status | Published - 2020 |
Keywords
- Fluorophenylpyrazole-picolinamide
- cross-coupling
- palladium-N-heterocyclic carbenes
- anticancer activity
- ONE-POT SYNTHESIS
- BIOLOGICAL EVALUATION
- PYRAZOLE DERIVATIVES
- ANTITUMOR AGENTS
- HYBRIDS
- DESIGN
- HETEROCYCLES
- CANCER